A randomized trial comparing influenza vaccines over two seasons found that recombinant vaccines showed stronger immune responses to A/H3N2 strains compared with egg-based and cell culture-based vaccines. ...
In this respiratory disease roundup, experts discuss the rising concerns over new cases of avian influenza in young people, the FDA's emergency approval of pemivibart monoclonal antibody for COVID-19, the...
The Advisory Committee on Immunization Practices released its updated annual immunization schedule for 2024 that includes new sections on respiratory syncytial virus (RSV), and the mpox (monkeypox) and...
Researchers examined patterns among individuals who previously used preventative services and vaccinations and later vaccinations for both influenza and COVID-19 among US adults.
The CDC updated its guidance due to the United States seeing fewer hospitalizations associated with COVID-19 and because there are numerous tools to combat influenza, COVID-19, and respiratory syncytial...
Researchers studied the risk and prevalence of individuals developing varicella-zoster reactivation after receiving mRNA COVID-19 vaccination compared with receiving influenza vaccination. Their findings...
Many pediatric patients who are recommended to receive two doses of the influenza vaccine do not receive both doses, despite vaccinations being associated with a significant decrease in the risk of...
An updated report for the use of the influenza vaccine and antiviral medications has been released from the American Academy of Pediatrics for the 2022-2023 influenza season.
